Claro Advisors’s Zimmer Biomet ZBH Stock Holding History

Claro Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-155	Closed	-$20K	–	963
2018 Q4	$20K	Buy	+155	New	+$17.4K	0.02%	545

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Claro Advisors's ZBH Position: Q1 2019 in Review

Claro Advisors sold out of Zimmer Biomet (ZBH) in Q1 2019, closing a stake of 155 shares — an estimated $20K sold.

Claro Advisors first reported a position in ZBH in Q4 2018 and held it in 1 quarter. The position peaked at $20K in Q4 2018. 897 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

Claro Advisors reported no remaining Zimmer Biomet position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 155 Zimmer Biomet shares in Q1 2019, an estimated $20K.
Claro Advisors first reported a position in Zimmer Biomet in Q4 2018 and held it in 1 quarter.
Claro Advisors's Zimmer Biomet position peaked at $20K in Q4 2018.
897 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.